These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30728807)

  • 1. Small Molecule Follicle-Stimulating Hormone Receptor Agonists and Antagonists.
    Anderson RC; Newton CL; Millar RP
    Front Endocrinol (Lausanne); 2018; 9():757. PubMed ID: 30728807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Programming of Endosomal Signaling Activated by Small Molecule Ligands of the Follicle Stimulating Hormone Receptor.
    Sposini S; De Pascali F; Richardson R; Sayers NS; Perrais D; Yu HN; Palmer S; Nataraja S; Reiter E; Hanyaloglu AC
    Front Pharmacol; 2020; 11():593492. PubMed ID: 33329002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
    Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
    Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of a novel long-acting recombinant follicle stimulating hormone agonist by fusing Fc to an FSH-β subunit.
    Zhang YL; Guo KP; Ji SY; Liu XM; Wang P; Wu J; Gao L; Jiang TQ; Xu T; Fan HY
    Hum Reprod; 2016 Jan; 31(1):169-82. PubMed ID: 26621853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicle-Stimulating Hormone Receptor: Advances and Remaining Challenges.
    De Pascali F; Tréfier A; Landomiel F; Bozon V; Bruneau G; Yvinec R; Poupon A; Crépieux P; Reiter E
    Int Rev Cell Mol Biol; 2018; 338():1-58. PubMed ID: 29699689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variations altering FSH action affect circulating hormone levels as well as follicle growth in healthy peripubertal girls.
    Busch AS; Hagen CP; Almstrup K; Main KM; Juul A
    Hum Reprod; 2016 Apr; 31(4):897-904. PubMed ID: 26905078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic profiling of corifollitropin alfa, the first developed sustained follicle stimulant.
    Verbost P; Sloot WN; Rose UM; de Leeuw R; Hanssen RG; Verheijden GF
    Eur J Pharmacol; 2011 Jan; 651(1-3):227-33. PubMed ID: 21115001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly and structural characterization of an authentic complex between human follicle stimulating hormone and a hormone-binding ectodomain of its receptor.
    Fan QR; Hendrickson WA
    Mol Cell Endocrinol; 2007 Jan; 260-262():73-82. PubMed ID: 17045735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency.
    Fauser BC; Mannaerts BM; Devroey P; Leader A; Boime I; Baird DT
    Hum Reprod Update; 2009; 15(3):309-21. PubMed ID: 19182099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and Development of Small Molecule Allosteric Modulators of Glycoprotein Hormone Receptors.
    Nataraja SG; Yu HN; Palmer SS
    Front Endocrinol (Lausanne); 2015; 6():142. PubMed ID: 26441832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corifollitropin alfa: a review of its use in controlled ovarian stimulation for assisted reproduction.
    Croxtall JD; McKeage K
    BioDrugs; 2011 Aug; 25(4):243-54. PubMed ID: 21815699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling of an allosteric, nanomolar potent, low molecular weight agonist for the follicle-stimulating hormone receptor.
    van Koppen CJ; Verbost PM; van de Lagemaat R; Karstens WJ; Loozen HJ; van Achterberg TA; van Amstel MG; Brands JH; van Doornmalen EJ; Wat J; Mulder SJ; Raafs BC; Verkaik S; Hanssen RG; Timmers CM
    Biochem Pharmacol; 2013 Apr; 85(8):1162-70. PubMed ID: 23415902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biased signalling in follicle stimulating hormone action.
    Landomiel F; Gallay N; Jégot G; Tranchant T; Durand G; Bourquard T; Crépieux P; Poupon A; Reiter E
    Mol Cell Endocrinol; 2014 Jan; 382(1):452-459. PubMed ID: 24121199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postendocytotic trafficking of the follicle-stimulating hormone (FSH)-FSH receptor complex.
    Krishnamurthy H; Kishi H; Shi M; Galet C; Bhaskaran RS; Hirakawa T; Ascoli M
    Mol Endocrinol; 2003 Nov; 17(11):2162-76. PubMed ID: 12907758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of Zebrafish Follicle-Stimulating Hormone Receptor (fshr) But Not Luteinizing Hormone Receptor (lhcgr) Gene by TALEN Leads to Failed Follicle Activation in Females Followed by Sexual Reversal to Males.
    Zhang Z; Lau SW; Zhang L; Ge W
    Endocrinology; 2015 Oct; 156(10):3747-62. PubMed ID: 25993524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption, distribution, metabolism and excretion of corifollitropin alfa, a recombinant hormone with a sustained follicle-stimulating activity.
    van Schanke A; van de Wetering-Krebbers SF; Bos E; Sloot WN
    Pharmacology; 2010; 85(2):77-87. PubMed ID: 20110752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FSHR Trans-Activation and Oligomerization.
    Szymańska K; Kałafut J; Przybyszewska A; Paziewska B; Adamczuk G; Kiełbus M; Rivero-Müller A
    Front Endocrinol (Lausanne); 2018; 9():760. PubMed ID: 30619090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Selective LH Receptor Agonists by Heterodimerization with a FSH Receptor Antagonist.
    Bonger KM; Hoogendoorn S; van Koppen CJ; Timmers CM; van der Marel GA; Overkleeft HS
    ACS Med Chem Lett; 2011 Jan; 2(1):85-9. PubMed ID: 24900256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corifollitropin alfa: a new option to treat female infertility.
    de Lartigue J
    Drugs Today (Barc); 2011 Aug; 47(8):583-90. PubMed ID: 21850281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of recombinant versus highly purified follicle-stimulating hormone according to follicle-stimulating hormone receptor genotype.
    Lledó B; Dapena P; Ortiz JA; Morales R; Llacer J; Bernabeu R
    Pharmacogenet Genomics; 2016 Jun; 26(6):288-93. PubMed ID: 26959715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.